Stock Analysts’ Updated EPS Estimates for June 15th (ASML, AVGO, AVNW, BLTE, CART, CLDX, CRC, CRNX, DDOG, DLB)

Stock Analysts’ updated eps estimates for Monday, June 15th:

ASML (NASDAQ:ASML) had its buy rating reaffirmed by analysts at Sanford C. Bernstein.

Broadcom (NASDAQ:AVGO) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Aviat Networks (NASDAQ:AVNW) was upgraded by analysts at Northland Securities from a market perform rating to an outperform rating. Northland Securities currently has $25.00 price target on the stock, up from their previous price target of $20.00.

Belite Bio (NASDAQ:BLTE) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $200.00 price target on the stock.

Maplebear (NASDAQ:CART) had its market outperform rating reissued by analysts at Citizens Jmp. Citizens Jmp currently has a $60.00 price target on the stock.

Celldex Therapeutics (NASDAQ:CLDX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $42.00 price target on the stock.

California Resources (NYSE:CRC) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Crinetics Pharmaceuticals (NASDAQ:CRNX) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $81.00 target price on the stock.

Datadog (NASDAQ:DDOG) was upgraded by analysts at Truist Financial Corporation from a hold rating to a buy rating. The firm currently has $300.00 target price on the stock, up from their previous target price of $190.00.

Dolby Laboratories (NYSE:DLB) had its outperform rating reaffirmed by analysts at Barrington Research. They currently have a $90.00 price target on the stock.

Harmonic (NASDAQ:HLIT) had its buy rating reissued by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $20.00 price target on the stock.

International Money Express (NASDAQ:IMXI) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Ionis Pharmaceuticals (NASDAQ:IONS) had its buy rating reissued by analysts at TD Cowen. The firm currently has a $108.00 target price on the stock.

Opus Genetics (NASDAQ:IRD) had its market outperform rating reiterated by analysts at Citizens Jmp. Citizens Jmp currently has a $11.00 target price on the stock.

Invivyd (NASDAQ:IVVD) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $10.00 price target on the stock.

Kura Oncology (NASDAQ:KURA) had its market outperform rating reissued by analysts at Citizens Jmp. Citizens Jmp currently has a $24.00 price target on the stock.

Kyivstar Group (NASDAQ:KYIV) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.

Lyell Immunopharma (NASDAQ:LYEL) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $44.00 target price on the stock.

Lyell Immunopharma (NASDAQ:LYEL) had its market outperform rating reaffirmed by analysts at Citizens Jmp. They currently have a $34.00 target price on the stock.

Metagenomi (NASDAQ:MGX) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.

Cloudflare (NYSE:NET) had its market outperform rating reaffirmed by analysts at Citizens Jmp. They currently have a $270.00 target price on the stock.

Nurix Therapeutics (NASDAQ:NRIX) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $34.00 target price on the stock.

Intellia Therapeutics (NASDAQ:NTLA) had its market outperform rating reissued by analysts at Citizens Jmp. They currently have a $30.00 price target on the stock.

Intellia Therapeutics (NASDAQ:NTLA) had its neutral rating reaffirmed by analysts at Wedbush. The firm currently has a $12.00 target price on the stock.

PACS Group (NYSE:PACS) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Piedmont Realty Trust (NYSE:PDM) had its buy rating reissued by analysts at Truist Financial Corporation. Truist Financial Corporation currently has a $11.00 price target on the stock, up from their previous price target of $10.00.

Rubrik (NYSE:RBRK) had its overweight rating reaffirmed by analysts at Stephens. The firm currently has a $90.00 target price on the stock.

SAB Biotherapeutics (NASDAQ:SABS) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $10.00 target price on the stock.

Satellogic (NASDAQ:SATL) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Sonos (NASDAQ:SONO) had its buy rating reiterated by analysts at Rosenblatt Securities. The firm currently has a $21.00 target price on the stock.

SOPHiA GENETICS (NASDAQ:SOPH) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $8.00 price target on the stock.

Sasol (NYSE:SSL) had its neutral rating reissued by analysts at JPMorgan Chase & Co..

Upstart (NASDAQ:UPST) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $37.00 price target on the stock.

Welltower (NYSE:WELL) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $238.00 target price on the stock.

Wix.com (NASDAQ:WIX) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $80.00 target price on the stock.